The pathophysiology of chronic constipation

Canadian Journal of Gastroenterology

Volumn 25, Issue SUPPL.B, 2011, Pages

  Andrews, Christopher N ^a   Storr, Martin ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colonic transit; Constipation; Defecation disorders; Dyssynergia

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BISACODYL; CALCIUM ANTAGONIST; CANNABINOID DERIVATIVE; CASCARA; CISAPRIDE; CLONIDINE; GANGLION BLOCKING AGENT; IRON; LACTULOSE; LUBIPROSTONE; MACROGOL 3350; MAGNESIUM HYDROXIDE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; PRUCALOPRIDE; SENNA EXTRACT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; SUCRALFATE; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; VINCA ALKALOID;

CHRONIC DISEASE; CONSTIPATION; DEFECATION; DISEASE SEVERITY; HUMAN; INTESTINE TRANSIT TIME; MULTIPLE SCLEROSIS; NEUROGENIC BOWEL; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; SYMPTOMATOLOGY; SYSTEMIC DISEASE; ANAL CANAL; GASTROINTESTINAL MOTILITY; INTESTINE ABSORPTION; PELVIS FLOOR; PHYSICAL EXAMINATION; PHYSIOLOGY; RECTUM;

ANAL CANAL; CHRONIC DISEASE; CONSTIPATION; DEFECATION; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL ABSORPTION; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PELVIC FLOOR; PHYSICAL EXAMINATION; RECTUM; SPINAL CORD INJURIES;

EID: 84859236846     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/169319     Document Type: Review

References (49)

1. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S5-S21.
2. Higgins PD, Johanson JF. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol 2004;99:750-9.
3. Pare P, Ferrazzi S, Thompson WG, Irvine EJ, Rance L. An epidemiological survey of constipation in Canada: Definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001;96:3130-7.
4. Sleisenger MH, Feldman M, Friedman LS, Brandt LJ. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, 8th edn. Philadelphia: Saunders, 2006:2127-46.
5. Sleisenger MH, Feldman M, Friedman LS, Brandt LJ. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 8th ed, Philadelphia: Saunders, 2006:2111-26.
6. Southwell BR, Clarke MC, Sutcliffe J, Hutson JM. Colonic transit studies: Normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int 2009;25:559-72.
7. Dinning PG, Smith TK, Scott SM. Pathophysiology of colonic causes of chronic constipation. Neurogastroenterol Motil 2009;21:20-30.
8. Grundy D, Al-Chaer ED, Aziz Q, et al. Fundamentals of neurogastroenterology: Basic science. Gastroenterology 2006;130:1391-411.
9. Bharucha AE. Pelvic floor: Anatomy and function. Neurogastroenterol Motil 2006;18:507-19.
10. Rao SS. Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation. Clin Gastroenterol Hepatol 2010;8:910-9.
11. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radioopaque markers. Gut 1969;10:842-7.
12. Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: Position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011;23:8-23.
13. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 1997;38:1807-10.
14. Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for colonic transit: Prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil 2010;22:874-82,e233.
15. Cash BD, Chey WD. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 2005;22:1047-60.
16. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
17. Ashraf W, Park F, Lof J, Quigley EM. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996;91:26-32.
18. Tack J, Muller-Lissner S. Treatment of chronic constipation: Current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009;7:502-8; quiz 496.
19. Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: 'Idiopathic slow transit constipation'. Gut 1986;27:41-8.
20. Bassotti G, Roberto GD, Sediari L, Morelli A. Toward a definition of colonic inertia. World J Gastroenterol 2004;10:2465-7.
21. He CL, Burgart L, Wang L, et al. Decreased interstitial cell of Cajal volume in patients with slow-transit constipation. Gastroenterology 2000;118:14-21.
22. Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996;8:1207-11.
23. Knowles CH, De Giorgio R, Kapur RP, et al. The London Classification of gastrointestinal neuromuscular pathology: Report on behalf of the Gastro 2009 International Working Group. Gut 2010;59:882-7.
24. Nyam DC, Pemberton JH, Ilstrup DM, Rath DM. Long-term results of surgery for chronic constipation. Dis Colon Rectum 1997;40:273-9.
25. Remes-Troche JM, Rao SS. Neurophysiological testing in anorectal disorders. Expert Rev Gastroenterol Hepatol 2008;2:323-35.
26. Rao SS. Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am 2008;37:569-86, viii.
27. Loening-Baucke V. Encopresis and soiling. Pediatr Clin North Am 1996;43:279-98.
28. Rao SS, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: A systematic review. Am J Gastroenterol 2005;100:1605-15.
29. Rao SS. Biofeedback therapy for constipation in adults. Best Pract Res Clin Gastroenterol 2011;25:159-66.
30. Storr M, Allescher HD. [Motility-modifying drugs]. Internist (Berl) 2000;41:1318-24, 26-30.
31. Fosnes GS, Lydersen S, Farup PG. Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population. BMC Clin Pharmacol 2011;11:2.
32. Simonson W, Han LF, Davidson HE. Hypertension treatment and outcomes in US nursing homes: Results from the US National Nursing Home Survey. J Am Med Dir Assoc 2011;12:44-9.
33. Dolder C, Nelson M, Stump A. Pharmacological and clinical profile of newer antidepressants: Implications for the treatment of elderly patients. Drugs Aging 2010;27:625-40.
34. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol 2003;98:1107-11.
35. Rosti G, Gatti A, Costantini A, Sabato AF, Zucco F. Opioid-related bowel dysfunction: Prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment. Eur Rev Med Pharmacol Sci 2010;14:1045-50.
36. Mjornheim AC, Finizia C, Blohme G, Attvall S, Lundell L, Ruth M. Gastrointestinal symptoms in type 1 diabetic patients, as compared to a general population. A questionnaire-based study. Digestion 2003;68:102-8.
37. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: Lack of association with neuropathy. Am J Gastroenterol 1989;84:868-72.
38. Takahashi T, Matsuda K, Kono T, Pappas TN. Inhibitory effects of hyperglycemia on neural activity of the vagus in rats. Intensive Care Med 2003;29:309-11.
39. He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001;121:427-34.
40. Horvath VJ, Vittal H, Lorincz A, et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology 2006;130:759-70.
41. Ordög T. Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil 2008;20:8-18.
42. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am 1998;27:861-74, vi-vii.
43. Sellin JH, Chang EB. Therapy insight: Gastrointestinal complications of diabetes - pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol 2008;5:162-71.
44. Glick ME, Meshkinpour H, Haldeman S, Bhatia NN, Bradley WE. Colonic dysfunction in multiple sclerosis. Gastroenterology 1982;83:1002-7.
45. Hinds JP, Wald A. Colonic and anorectal dysfunction associated with multiple sclerosis. Am J Gastroenterol 1989;84:587-95.
46. Preziosi G, Emmanuel A. Neurogenic bowel dysfunction: Pathophysiology, clinical manifestations and treatment. Expert Rev Gastroenterol Hepatol 2009;3:417-23.
47. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-62.
48. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Mov Disord 2008;23:1065-75.
49. Dinning PG, Szczesniak MM, Cook IJ. Twenty-four hour spatiotemporal mapping of colonic propagating sequences provides pathophysiological insight into constipation. Neurogastroenterol Motil 2008;20:1017-21.